头颈癌显微血管重建后患者报告的美学与心理社会结局
这项横断面网络调查纳入228例2015至2019年间接受显微血管游离组织移植的头颈癌患者,124例(54.4%)完成FACE-Q问卷,中位随访34.4个月。骨皮瓣重建和辅助放化疗独立降低面部外观满意度,而外观满意度与外观相关心理社会功能受损独立相关。
要点
- 骨皮瓣重建和辅助放化疗是长期面部外观满意度降低的独立危险因素。
- 女性、焦虑抑郁史、骨皮瓣、长期管饲、复发或持续病变与外观相关心理社会功能受损独立相关。
- 面部外观满意度每提高1分,外观相关心理社会功能各量表均独立改善。
核心结论
- 骨皮瓣重建和辅助治疗独立增加患者报告长期美学满意度差的风险,且美学满意度与外观相关心理社会功能受损相关。
研究设计与样本
- 横断面网络调查,在学术三级医疗中心开展,纳入228例2015年1月1日至2019年12月31日因头颈癌接受显微血管游离组织移植的患者。
主要发现
- 应答者中79例(63.7%)为男性,多为口腔或皮肤晚期癌症,采用股前外侧皮瓣或骨皮瓣腓骨游离皮瓣重建。
- 面部外观满意度评分在骨皮瓣重建者中独立更低(回归系数-10.6分,95%CI -20.4至-0.8分),在辅助放化疗者中也独立更低(回归系数-6.9分,95%CI -13.8至-0.1分)。
- 外观相关心理社会功能受损独立与女性、焦虑或抑郁史、骨皮瓣、长期管饲需求及任何复发或持续病变相关。
- 面部外观满意度每增加1分,外观相关心理社会困扰量表评分独立降低0.5分(95%CI -0.7至-0.4分),心理功能量表评分独立增加0.4分(95%CI 0.3至0.5分),社会功能量表评分独立增加0.4分(95%CI 0.3至0.6分)。
临床怎么用
- 对接受显微血管游离组织移植的头颈癌患者,尤其是骨皮瓣重建或辅助放化疗者,应关注长期美学满意度并筛查外观相关心理社会功能受损。
- 女性、有焦虑抑郁史、长期管饲或复发/持续病变的患者可能需重点心理社会支持。
局限性
- 横断面设计无法确定因果关系。
- 应答率54.4%,虽非应答者基线特征无显著差异,仍可能存在选择偏倚。
- 单中心学术三级医疗中心结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Aesthetic outcomes are key determinants of psychosocial functioning among surgically treated patients with head and neck cancer (HNC); however, long-term aesthetic outcomes after microvascular free tissue transfer (MFTT) are not well described. OBJECTIVE: To examine risk factors for impaired long-term aesthetic satisfaction and appearance-related psychosocial functioning after HNC ablation with MFTT. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional, web-based survey was conducted at an academic tertiary care center. A total of 228 individuals who underwent MFTT between January 1, 2015, and December 31, 2019, for treatment of HNC were included. The study was conducted from November 1, 2020, through January 15, 2021. EXPOSURES: Head and neck cancer ablation with MFTT. MAIN OUTCOMES AND MEASURES: Patient-reported outcomes were assessed via Aesthetic FACE-Q scales. The primary objective was aesthetic satisfaction determined by the Satisfaction With Facial Appearance scale. Secondarily, the Appearance-Related Psychosocial Distress, Psychological Function, and Social Function scales were used to assess appearance-related psychosocial functioning. Patients were stratified by demographic, disease, surgical, and postoperative characteristics. Survey scores on a 100-point scale were compared and subjected to univariable and multivariable linear regression. RESULTS: A total of 124 of 228 patients (54.4%) completed surveys a median of 34.4 months after MFTT (interquartile range, 22.6-48.8). Most responders (79 [63.7%]) were men with advanced cancer of the oral cavity or skin, reconstructed with anterolateral thigh or osteocutaneous fibula free flaps. Nonresponders had no significant differences in baseline characteristics. The Satisfaction With Facial Appearance score was independently lower among patients who received osteocutaneous flaps (regression coefficient, -10.6 points, 95% CI, -20.4 to -0.8 points) and/or adjuvant (chemo)radiotherapy (regression coefficient, -6.9 points; 95% CI, -13.8 to -0.1 points). Impaired appearance-related psychosocial functioning was independently associated with female sex, a history of anxiety or depression, osteocutaneous flaps, prolonged tube feeding requirements, and any recurrent or persistent disease. After adjustment for covariates, each 1-point increase in the Satisfaction With Facial Appearance score independently estimated improved appearance-related psychosocial functioning as determined by the Appearance-Related Psychosocial Distress scale (regression coefficient, -0.5 points; 95% CI, -0.7 to -0.4 points), Psychological Function scale (regression coefficient, 0.4 points; 95% CI, 0.3 to 0.5 points), and Social Function scale (regression coefficient, 0.4 points; 95% CI, 0.3 to 0.6 points). CONCLUSIONS AND RELEVANCE: The findings of this cross-sectional, web-based survey study suggest that osteocutaneous reconstruction and adjuvant therapy independently increase the risk of poor patient-reported long-term aesthetic satisfaction, which correlated with impaired appearance-related psychosocial functioning. Aesthetic outcomes appear to be a priority to address in patients with HNC undergoing MFTT.
引用
- Zebolsky AL, Patel N, Heaton CM, et al. Patient-Reported Aesthetic and Psychosocial Outcomes After Microvascular Reconstruction for Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 34292310. doi:10.1001/jamaoto.2021.1563
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。